In vivo use of water absorbent polymers

a technology of water absorbent polymers and polymers, which is applied in the direction of antinoxious agents, extracellular fluid disorders, metabolic disorders, etc., can solve the problems of reducing cardiac output, reducing cardiac output, and reducing the heart's ability to pump blood, so as to improve the fluid absorbing performance and less interference

Inactive Publication Date: 2005-02-17
SORBENT THERAPEUTICS
View PDF11 Cites 52 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The enteric coatings used to encapsulate or coat the subject polymers ensure that fluid removal occurs substantially in the intestine rather than the stomach. By preventing the polymers from becoming active in the stomach, the present invention also allows the polymers to absorb more fluid secreted into the intestinal tract which contains metabolic waste products rather than recently ingested die

Problems solved by technology

Many cardiac diseases can lead to compromise in the heart's ability to pump blood.
This fibrotic tissue is not capable of pumping blood and results in a decrease in the cardiac output.
Cardiomyopathy causes the heart muscle to have less strength resulting in reduced cardiac output.
This congestive heart failure can cause fluid to leak from the vascular space into the extravascular space to cause edema of the tissue involved, e.g. pulmonary edema, edema of the legs, etc.
Diseases of the kidney can also lead to fluid overload states.
For example, nephrosis and nephritis cause decreases in the ability of the kidney to excrete urine with resultant fluid retention in the body and formation of edema.
Acute and chronic renal failure compromise or eliminate the production of urine, resulting in fluid overload of the body.
Intestinal or nutritional disorders can result in decreased serum protein levels.
Particularly when the serum albumin levels are decreased, the colloidal pressure in the vascular space is inadequate to retain fluid in the blood vessels and tissue edema forms.
Hepatic disease can also lead to fluid overload states.
Cirrhosis of the liver results in decreased synthesis of serum proteins such as albumin.
It also causes obstruction to blood flow from the body below the diaphragm to the heart.
This obstruction causes increased pressure the vasculature with resultant edema formation below the diaphragm, ascites formation, and decreased blood flow to the kidneys.
Hormonal alterations, such as the syndrome of inappropriate antidiuretic syndrome and states with high progesterone levels, can result in fluid retention and overload.
Pulmonary diseases, such as pulmonary fibrosis and chronic obstructive pulmonary diseases, also result in fluid overload states.
In addition to the fluid overload, many of these conditions cause buildup of other substances.
Any condition that compromises urinary output can result in increases in urea, creatinine, other nitrogenous waste products, and electrolytes or minerals such as sodium, phosphate, and potassium.
If untreated, the build up of water (i.e. fluid overload) and other blood borne waste products can lead to unpleasant symptoms and serious medical complications.
Peripheral edema can be painful and cause clothing to be too tight.
The swelling from the edema can compromise the blood flow to or from the tissues resulting in infections or ulcers.
Pulmonary edema causes difficulty in absorbing enough oxygen to properly oxygenate tissues.
Ascites can be quite painful.
Edema of the intestine secondary to liver disease causes malabsorption of nutrients leading to malnutrition.
Ammonia retention can result in neurological damage.
Any organic acid in excess can cause metabolic acidosis with resultant dysfunction of pH dependent processes such as enzymatic metabolic reactions.
Ischemic tissues with increased lact

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

example 1

A bead form of absorbent polymer based on a partial sodium salt of lightly crosslinked polyacrylic acid was prepared in a fashion similar to that given in Example 1 of EP 314825. Acrylic acid, neutralized with sodium hydroxide and dissolved in water, was mixed with the pentasodium salt of diethylenetriaminepentaacetic acid and added to a reactor charged with Isopar L and Aerosil R972 held at 65° C. Trimethylolpropane triacrylate and a solution of sodium persulfate were added with vigorous stirring. The product of the reaction was removed from the reactor, filtered, washed with ethanol, and dried under vacuum. The resultant polymer had an absorbance capacity of 45 gram 0.9% saline solution per gram of polymer.

example 2

The bead form of polymer from Example 1 was coated with a 5% coating of hydroxypropylmethylcellulose followed by a subsequent enteric coating of a 17.5% coating of Sureteric (polyvinyl acetate phthalate).

example 3

Six male beagle dogs underwent removal of the right kidney and ligation of seven of the eight branches of the left renal artery. Following one week of recovery time, the blood chemistries revealed that all of the dogs were in renal failure. Two dogs were then started on 1 gram of polymer from Example 1 per kg body weight per day in two divided doses given with food. Two more dogs were started on 1 gram of polymer as the enteric coated beads from Example 2 in two divided doses given with food. Two dogs were followed as controls. On the seventh and fourteenth day of receiving the polymer, each dog was given capsules containing a total of 73 mg ampicillin, 38 mg phenobarbital, and 8.8 mg zinc simultaneously with the dose of polymer. Blood was drawn just before and again two hours after the capsules were given. Serum ampicillin rose to an average of 2.3 mg / L in the control dogs, 1.4 mg / L in the dogs given uncoated polymer, and 2.6 mg / L in the dogs given the enteric coated polymer. Seru...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Weightaaaaaaaaaa
Water absorptionaaaaaaaaaa
Login to view more

Abstract

The subject invention is a method and material for removing fluid from the intestinal tract of a host and may be useful in treating animals or human patients suffering from fluid overload states. In one embodiment, the subject method involves ingesting an enterically coated non-systemic, non-toxic, non-digestible, water absorbing polymer which absorbs fluid while passing through the intestinal tract. The polymer is excreted in the feces wherein the polymer and absorbed fluid is removed from the body. Preferred polymers include super absorbent acrylic acid polymers, preferably provided in bead form. The polymers may include functional groups for selectively removing blood borne waste products, e.g. urea, from the G.I. tract.

Description

BACKGROUND OF THE INVENTION Fluid overload states are associated with a number of serious medical conditions. Many cardiac diseases can lead to compromise in the heart's ability to pump blood. Myocardial infarction frequently causes the replacement of heart muscle by fibrotic tissue. This fibrotic tissue is not capable of pumping blood and results in a decrease in the cardiac output. Cardiomyopathy causes the heart muscle to have less strength resulting in reduced cardiac output. These and other cardiac diseases result in blood pooling in the pulmonary vasculature and even in peripheral tissues such as the feet and legs. This congestive heart failure can cause fluid to leak from the vascular space into the extravascular space to cause edema of the tissue involved, e.g. pulmonary edema, edema of the legs, etc. The reduced cardiac output causes lowered blood flow to the kidneys which decreases the urinary output. Diseases of the kidney can also lead to fluid overload states. For exam...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/50A61K9/16A61K9/52A61K31/715A61K31/716A61K31/74A61K31/78A61K31/785A61K47/32A61K47/38A61P3/00A61P7/00A61P7/10A61P9/04A61P9/10A61P13/12
CPCA61K9/1635A61K9/5073A61K31/715A61K47/32A61K31/74A61K31/78A61K31/716A61P1/00A61P3/00A61P7/00A61P7/10A61P9/04A61P9/10A61P13/12A61P39/02
Inventor SIMON, JAIMESTRICKLAND, ALAN D.
Owner SORBENT THERAPEUTICS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products